Search All UT System Experts

Therapeutic benefit of bortezomib on acute graft-versus-host disease is tissue specific and is associated with interleukin-6 levels

Chien Chun Steven Pai, Hui Hua Hsiao, Kai Sun, Mingyi Chen, Takeshi Hagino, Joseph Tellez, Christine Mall, Bruce R. Blazar, Arta Monjazeb, Mehrdad Abedi, William J. Murphy

Research output: Contribution to journal › Article › peer-review

21 Scopus citations

Fingerprint

Dive into the research topics of 'Therapeutic benefit of bortezomib on acute graft-versus-host disease is tissue specific and is associated with interleukin-6 levels'. Together they form a unique fingerprint.

Medicine & Life Sciences